Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes
-
Add time:07/19/2019 Source:sciencedirect.com
Background and aimsCirculating soluble urokinase plasminogen activator receptor (suPAR) is a marker of immune activation associated with atherosclerosis. Whether suPAR levels are associated with prevalent peripheral arterial disease (PAD) and its adverse outcomes remains unknown and is the aim of the study.
We also recommend Trading Suppliers and Manufacturers of delta(2-89)-tissue plasminogen activator (cas 105913-11-9). Pls Click Website Link as below: cas 105913-11-9 suppliers
Prev:Chlorhexidine delivery system from titanium/polybenzyl acrylate coating: Evaluation of cytotoxicity and early bacterial adhesion
Next:A theory of reactant-stationary kinetics for a mechanism of zymogen activation) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Pharmacokinetics and Pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease07/22/2019
- Large Hepatitis Delta Antigen Modulates Transforming Growth Factor-β Signaling Cascades: Implication of Hepatitis Delta Virus–Induced Liver Fibrosis07/20/2019
- A theory of reactant-stationary kinetics for a mechanism of zymogen activation07/21/2019
-
Health and Chemical more >